Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up H Kadara, M Choi, J Zhang, ER Parra, J Rodriguez-Canales, SG Gaffney, ... Annals of Oncology 28 (1), 75-82, 2017 | 194 | 2017 |
Early and multiple origins of metastatic lineages within primary tumors ZM Zhao, B Zhao, Y Bai, A Iamarino, SG Gaffney, J Schlessinger, ... Proceedings of the National Academy of Sciences 113 (8), 2140-2145, 2016 | 158 | 2016 |
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function M Choi, H Kadara, J Zhang, ER Parra, J Rodriguez-Canales, SG Gaffney, ... Annals of Oncology 28 (1), 83-89, 2017 | 101 | 2017 |
APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma VL Cannataro, SG Gaffney, T Sasaki, N Issaeva, NKS Grewal, JR Grandis, ... Oncogene 38 (18), 3475-3487, 2019 | 90 | 2019 |
Effect sizes of somatic mutations in cancer VL Cannataro, SG Gaffney, JP Townsend JNCI: Journal of the National Cancer Institute 110 (11), 1171-1177, 2018 | 74 | 2018 |
Combined aurora kinase A (AURKA) and WEE1 inhibition demonstrates synergistic antitumor effect in squamous cell carcinoma of the head and neck JW Lee, J Parameswaran, T Sandoval-Schaefer, KJ Eoh, D Yang, F Zhu, ... Clinical Cancer Research 25 (11), 3430-3442, 2019 | 68 | 2019 |
Molecular biology and evolution of cancer: from discovery to action JA Somarelli, H Gardner, VL Cannataro, EF Gunady, AM Boddy, ... Molecular biology and evolution 37 (2), 320-326, 2020 | 65 | 2020 |
CDKN2A copy number loss is an independent prognostic factor in HPV-negative head and neck squamous cell carcinoma WS Chen, RS Bindra, A Mo, T Hayman, Z Husain, JN Contessa, ... Frontiers in oncology 8, 95, 2018 | 42 | 2018 |
Harnessing case isolation and ring vaccination to control Ebola C Wells, D Yamin, ML Ndeffo-Mbah, N Wenzel, SG Gaffney, JP Townsend, ... PLoS neglected tropical diseases 9 (5), e0003794, 2015 | 42 | 2015 |
Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C VL Cannataro, SG Gaffney, C Stender, ZM Zhao, M Philips, AE Greenstein, ... Oncogene 37 (18), 2444-2455, 2018 | 32 | 2018 |
Transfer RNA methyltransferase gene NSUN2 mRNA expression modifies the effect of T cell activation score on patient survival in head and neck squamous carcinoma L Lu, SG Gaffney, VL Cannataro, J Townsend Oral oncology 101, 104554, 2020 | 18 | 2020 |
Environmental and sex-specific molecular signatures of glioma causation EB Claus, VL Cannataro, SG Gaffney, JP Townsend Neuro-oncology 24 (1), 29-36, 2022 | 15 | 2022 |
Characterizing risk of Ebola transmission based on frequency and type of case–contact exposures LA Skrip, MP Fallah, SG Gaffney, R Yaari, D Yamin, A Huppert, L Bawo, ... Philosophical Transactions of the Royal Society B: Biological Sciences 372 …, 2017 | 14 | 2017 |
Number of HIV-1 founder variants is determined by the recency of the source partner infection CJ Villabona-Arenas, M Hall, KA Lythgoe, SG Gaffney, RR Regoes, ... Science 369 (6499), 103-108, 2020 | 12 | 2020 |
The landscape of novel and complementary targets for immunotherapy: an analysis of gene expression in the tumor microenvironment SG Gaffney, EB Perry, PM Chen, A Greenstein, SM Kaech, JP Townsend Oncotarget 10 (44), 4532, 2019 | 10 | 2019 |
PathScore: a web tool for identifying altered pathways in cancer data SG Gaffney, JP Townsend Bioinformatics 32 (23), 3688-3690, 2016 | 10 | 2016 |
Premetastatic shifts of endogenous and exogenous mutational processes support consolidative therapy in EGFR-driven lung adenocarcinoma JN Fisk, AR Mahal, A Dornburg, SG Gaffney, S Aneja, JN Contessa, ... Cancer letters 526, 346-351, 2022 | 9 | 2022 |
Clone phylogenetics reveals metastatic tumor migrations, maps, and models A Chroni, S Miura, L Hamilton, T Vu, SG Gaffney, V Aly, S Karim, ... Cancers 14 (17), 4326, 2022 | 4 | 2022 |
GEM-NET: lessons in multi-institution teamwork using collaboration software SG Gaffney, O Ad, S Smaga, A Schepartz, JP Townsend ACS central science 5 (7), 1159-1169, 2019 | 4 | 2019 |
CDKN2A copy number loss in HPV-and HPV+ head and neck cancer to indicate poor prognosis: An integrated genomic and clinical TCGA analysis. WS Chen, R Bindra, A Mo, T Hayman, Z Husain, JN Contessa, ... Journal of Clinical Oncology 35 (15_suppl), 6060-6060, 2017 | 3 | 2017 |